Bormioli Pharma: the new order
More than a year after entering the ownership of the Triton fund, Bormioli Pharma is carrying out a thorough review of its corporate policies, redefining brand identity and objectives, while underling its loyalty to the core business of a specialized supplier of the pharmaceutical market, with integrated containers of hollow and plastic glass, tamper evident closures and accessories.
Independent, with a prominent position in Europe, it looks towards the global market with an internationalization plan that provides, in the first place, further consolidation in the United States.
This is the intention of Bormioli Pharma that, in addition to the actions taken to improve the efficiency and productivity of existing platforms, has embarked on a program of renewal, where the design of a “holistic” model of innovation stands out.
«In practice - suggests Enrico Santarelli, Innovation and Marketing Manager of the company - this translates into a more open approach to the market and a greater attention to the needs and wellbeing of consumers/patients, moving from the unification of marketing and innovation functions to speed up the time to market of products, to suggesting more creative and personalized packaging solutions than ever before.
This is leading us to play a truly proactive role towards the pharmaceutical concerns, to which we obviously continue to guarantee state-of-the-art packaging, characterized by high quality standards».
Red passion and new visions, even digital. Bormioli Pharma, after the change of ownership from Vision Capital to the Triton investment fund, is therefore working on a paradigm shift in relations with the market, to which it proposes itself in a - we would say - unconventional way.
But it is a deft mutation, like the small stylized heart and the sophisticated lettering that appear in the new logo, with which the company today “signs” projects and productions.
«We have not given up on a touch of red, a tribute to the image and the many years of previous activities as Bormioli Rocco - explains Santarelli - and a sign capable of making a difference in the pharmaceutical world dominated, we know, by subdued colors.
Another reason for rejecting tradition is the way in which we want to present our products. It is therefore no coincidence that, at the Pharmapack 2019 international event in Paris, we involved the architect Carlo Ratti who has designed an interactive installation for us, recreating a rather unusual experience of consumption and use of pharmaceutical packaging: thanks to the adoption of digital technologies, our products have been able to “speak” to consumers/patients in a clearer and more immediate way».
New packaging concepts
Looking at patients as the true engine of innovation in the pharmaceutical field: Bormioli Pharma’s most innovative proposals are born from a different attention to the needs of the consumer.
The most recent ones include AccuRec, a high-tech dual chamber packaging system, which enables the accurate reconstitution of oral products (including food supplements), guaranteeing their safety and maintaining the properties of the ingredients unchanged.
In a few simple steps, patients can then reconstitute a wide range of oral drugs right in the packaging container: the pre-dosed solvent and the drug powder are in fact stored in separate chambers, in a tamper-evident and childproof device. A simple twist releases the powder into the solvent at the time of dosing, immediately before consumption.
